$CACI

Gordon Susan M. sold $132K of CACI

Gordon Susan M. sold 264 shares of CACI INTERNATIONAL INC /DE/ (CACI) at $500.38 ($0.13M total) on 2026-06-16.

Original reporting
SEC EDGAR · Gordon Susan M.
Published Jun 18, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 11:52 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CACI
Neutral
high confidence
Mentioned
$CACI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CACINeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price per share, and post-transaction holdings. It does not include any company guidance, contract, or regulatory development.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no fundamental catalyst in the text.

03

What to watch

The text does not state whether the sale was part of a broader pattern, tax planning, or other concurrent transactions; without that, interpreting bearish intent is speculative.

Relevance 4/10Novelty 3/10Timing: filed 2026-06-18, transaction dated 2026-06-16

Background

The article is an SEC Form 4 insider transaction disclosure for CACI International Inc. director Gordon Susan M.

Company-level read

Ticker impact

$CACINeutralHigh confidence
Context

CACI director Gordon Susan M. sold 264 shares in an open-market transaction for about $132.1K, per a fresh SEC Form 4 filing.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited and short-lived unless paired with other news.

Evidence & confidence

The filing is a routine Form 4 insider transaction with no 10b5-1 plan and no accompanying operational or guidance change disclosed in the text.

Market effects

No sector-level signal; insider sale at a single defense/IT services name without additional context.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification or personal liquidity needs, so the market may overreact relative to the informational content.

Key entities

  • CACI International Inc.

    Defense/IT services company subject of the insider transaction disclosure.

  • Gordon Susan M.

    Director who sold 264 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CACIHighAI 8/10

CACI International Inc (CACI) (Q1 2027) Earnings Call Highlights: Record

CACI International reported Q1 2027 earnings with 2.1% organic growth, citing supply chain constraints and budget uncertainty. CEO John Mengucci highlighted a clear strategy and disciplined execution. The company expects stronger growth in the second half, supported by funded backlog growth and recent awards. Integration of acquisitions like ARKA is affecting revenue recognition timing. CACI manages 1,900 programs with varying margins and focuses on long-term investments.

$CACIHighAI 8/10

CACI (CACI) Q1 2027 Earnings Call Transcript

CACI reported Q1 2027 revenue growth of 8%, EBITDA margin of 13.3%, and adjusted EPS increase of 12%. The company generated $133M in free cash flow and won $4.8B in awards. CACI raised its full-year guidance, citing strong demand for its technology, particularly in electronic warfare and space domains. The company is investing in manufacturing capacity to meet demand.

$CACIMed

What CACI International (CACI) Said on Its Q1 Earnings Call

CACI International reported Q1 earnings, highlighting new contracts like Apollo and SOFETOPS 2, and demand for electronic warfare and counter-UAS systems. The company expects to complete Space Development Agency Tranche 1 deliveries this year. CACI opened a new manufacturing center and plans to reduce leverage to 3x by March 2027. Management expressed confidence in the outlook despite a sluggish funding environment.

$CACIHighAI 8/10

CACI Q1 FY27 slides: margin expansion drives guidance raise

CACI International reported Q1 FY27 revenue of $2.47B, up 8.2% YoY but below estimates. EBITDA margin expanded to 13.3%, and EPS beat estimates by 17%. The company raised its FY27 guidance, citing strong profitability and margin expansion. Shares rose 3% premarket. According to CACI, the new guidance reflects improved business visibility and strategic investments.

$CACIMedAI 8/10

CACI (NYSE:CACI) misses Q3 CY2026 sales expectations

CACI reported Q3 CY2026 revenue of $2.47B, missing estimates by 1.4% but beating on adjusted EPS ($7.66 vs $6.60). Adjusted EBITDA also exceeded expectations. The company raised full-year revenue and EPS guidance. Operating margin was steady, but free cash flow margin declined. Backlog remained unchanged at $34B.